Suppr超能文献

血液肿瘤患者居家环境下药物不依从的流行状况及相关因素。

Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation.

机构信息

Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.

Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.

出版信息

BMC Cancer. 2017 Nov 9;17(1):739. doi: 10.1186/s12885-017-3735-1.

Abstract

BACKGROUND

Medication non-adherence is associated with poor health outcomes and increased health care costs. Depending on definitions, reported non-adherence rates in cancer patients ranges between 16 and 100%, which illustrates a serious problem. In malignancy, non-adherence reduces chances of achievement of treatment response and may thereby lead to progression or even relapse. Except for Chronic Myeloid Leukemia (CML), the extent of non-adherence has not been investigated in hematological-oncological patients in an outpatient setting. In order to explore ways to optimize cancer treatment results, this study aimed to assess the prevalence of self-administered medication non-adherence and to identify potential associated factors in hematological-oncological patients in their home situation.

METHODS

This is an exploratory cross-sectional study, carried out at the outpatient clinic of the Department of Hematology at the VU University medical center, Amsterdam, the Netherlands between February and April 2014. Hematological-oncological outpatients were sent questionnaires retrieving information on patient characteristics, medication adherence, beliefs about medication, anxiety, depression, coping, and quality of life. We performed uni- and multivariable analysis to identify predictors for medication non-adherence.

RESULTS

In total, 472 participants were approached of which 259 (55%) completed the questionnaire and met eligibility criteria. Prevalence of adherence in this group (140 male; 54,1%; median age 60 (18-91)) was 50%. In univariate analysis, (lower) age, (higher) education level, living alone, working, perception of receiving insufficient social support, use of bisphosphonates, depression, helplessness (ICQ), global health, role function, emotional function, cognitive function, social functioning, fatigue, dyspnea, diarrhea were found to be significantly related (p = <0.20) to medication non-adherence. In multivariable analysis, younger age, (higher) education level and fatigue remained significantly related (p = <0.10) to medication non-adherence.

CONCLUSIONS

This cross-sectional study shows that 50% of the participants were non-adherent. Lower age, living alone and perception of insufficient social support were associated factors of non-adherence in hematological-oncological adult patients in their home-situation.

摘要

背景

药物依从性差与健康状况不佳和医疗保健费用增加有关。根据不同的定义,癌症患者的报告不依从率在 16%至 100%之间,这说明了一个严重的问题。在恶性肿瘤中,不依从会降低治疗反应的机会,从而导致疾病进展甚至复发。除慢性髓性白血病(CML)外,在门诊环境中尚未研究血液肿瘤患者的不依从程度。为了探索优化癌症治疗结果的方法,本研究旨在评估血液肿瘤患者在家中自我管理药物不依从的发生率,并确定潜在的相关因素。

方法

这是一项探索性横断面研究,于 2014 年 2 月至 4 月在荷兰阿姆斯特丹 VU 大学医学中心血液科门诊进行。血液肿瘤门诊患者收到了问卷,以获取患者特征、药物依从性、药物信念、焦虑、抑郁、应对和生活质量信息。我们进行了单变量和多变量分析,以确定药物不依从的预测因素。

结果

共接触了 472 名参与者,其中 259 名(55%)完成了问卷并符合入选标准。该组的依从率(140 名男性;54.1%;中位年龄 60(18-91)岁)为 50%。在单变量分析中,(较低)年龄、(较高)教育程度、独居、工作、感知到社会支持不足、使用双膦酸盐、抑郁、无助感(ICQ)、总体健康、角色功能、情绪功能、认知功能、社会功能、疲劳、呼吸困难、腹泻与药物不依从显著相关(p<0.20)。在多变量分析中,年龄较小、(较高)教育程度和疲劳仍然与药物不依从显著相关(p<0.10)。

结论

这项横断面研究表明,50%的参与者不依从。年龄较小、独居和感知到社会支持不足是血液肿瘤成年患者在家中不依从的相关因素。

相似文献

2
Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia.
J Oncol Pharm Pract. 2015 Feb;21(1):19-25. doi: 10.1177/1078155213520261. Epub 2014 Feb 6.
4
To adhere or not to adhere: Rates and reasons of medication adherence in hematological cancer patients.
Crit Rev Oncol Hematol. 2016 Jan;97:247-62. doi: 10.1016/j.critrevonc.2015.08.025. Epub 2015 Sep 26.
6
Exploring variables associated with medication non-adherence in patients with COPD.
Int J Clin Pharm. 2019 Oct;41(5):1202-1209. doi: 10.1007/s11096-019-00895-3. Epub 2019 Aug 30.
8
Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction.
Int J Clin Pharm. 2016 Apr;38(2):280-8. doi: 10.1007/s11096-015-0235-8. Epub 2015 Dec 29.

引用本文的文献

2
Can Technology Solve the Problem of Medication Nonadherence?
Mayo Clin Proc Digit Health. 2023 Dec 22;2(1):34-37. doi: 10.1016/j.mcpdig.2023.11.008. eCollection 2024 Mar.
4
The Impact of Home Medication Management Practices on Medication Adherence.
Behav Sci (Basel). 2024 Sep 11;14(9):804. doi: 10.3390/bs14090804.
5
Co-designing a motivational interviewing training platform to enhance oncology healthcare professional communication.
PEC Innov. 2024 Aug 22;5:100335. doi: 10.1016/j.pecinn.2024.100335. eCollection 2024 Dec 15.
9
Immunomodulator adherence in multiple myeloma patients with lower socioeconomic status: a retrospective study.
Support Care Cancer. 2024 Jun 4;32(7):407. doi: 10.1007/s00520-024-08619-8.
10
Dynamic Projection of Medication Nonpersistence and Nonadherence Among Patients With Early Breast Cancer.
JAMA Netw Open. 2024 May 1;7(5):e2411909. doi: 10.1001/jamanetworkopen.2024.11909.

本文引用的文献

1
Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries.
J Cancer Res Clin Oncol. 2017 Jul;143(7):1167-1176. doi: 10.1007/s00432-017-2372-z. Epub 2017 Mar 13.
2
How could patient reported outcomes improve patient management in chronic myeloid leukemia?
Expert Rev Hematol. 2017 Jan;10(1):9-14. doi: 10.1080/17474086.2017.1262758. Epub 2016 Nov 30.
3
Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice.
Front Pharmacol. 2016 Sep 21;7:310. doi: 10.3389/fphar.2016.00310. eCollection 2016.
4
To adhere or not to adhere: Rates and reasons of medication adherence in hematological cancer patients.
Crit Rev Oncol Hematol. 2016 Jan;97:247-62. doi: 10.1016/j.critrevonc.2015.08.025. Epub 2015 Sep 26.
5
Medication adherence in gout: a systematic review.
Arthritis Care Res (Hoboken). 2014 Oct;66(10):1551-9. doi: 10.1002/acr.22336.
6
Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review.
Ann Oncol. 2014 Mar;25(3):564-577. doi: 10.1093/annonc/mdt433. Epub 2013 Nov 26.
7
Adherence and patients' experiences with the use of oral anticancer agents.
Acta Oncol. 2014 Feb;53(2):259-67. doi: 10.3109/0284186X.2013.844353. Epub 2013 Nov 22.
8
Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review.
Cancer Treat Rev. 2013 Oct;39(6):610-21. doi: 10.1016/j.ctrv.2012.12.014. Epub 2013 Feb 19.
10
Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia.
Leuk Res. 2012 Jul;36(7):817-25. doi: 10.1016/j.leukres.2012.01.021. Epub 2012 Feb 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验